CorePlus and Ibex Expand Partnership with Clinical Deployment of AI-Powered Diagnostics for TURP
Digital pathology leader surpasses 250,000 AI-based analyses in routine clinical use as it incorporates Ibex Prostate for TURP to further
Awards
Ibex Announces 2025 Customer Awards
We are thrilled to announce the 2025 recipients of our annual customer awards: The Ibex Trailblazer Awards, the John Theunissen
Ibex Announces 2024 Customer Awards
We are thrilled to introduce our new customer awards: The Ibex Trailblazer Awards & the John Theunissen Integration Award. These
Ibex Medical Analytics wins Edison Bronze Award for AI-powered breast cancer diagnostics solution
Ibex Breast HER2 Aids Pathologists in Setting Higher Standards for Accurate and Reproducible Biomarker Scoring to Improve Patient Management BOSTON,
Dedalus and Ibex launch an end-to-end AI-powered digital pathology solution, streamlining cancer diagnosis across Europe
Milan, Italy, November 30th, 2023 – Dedalus Group (“Dedalus”), the leading anatomic pathology information systems provider in Europe, and Ibex
Ibex Medical Analytics achieves HITRUST certification demonstrating the highest level of information protection assurance
The HITRUST Certification Validates Ibex’s Commitment to Strong Cybersecurity and Meeting Key Regulations to Protect Sensitive Data Boston, Massachusetts –
Roche collaborates with Ibex and Amazon Web Services to accelerate adoption of AI-enabled digital pathology solutions to help improve cancer diagnoses
Roche’s navify Digital Pathology software platform now offers Ibex’s Artificial Intelligence (AI) algorithms to support clinicians in the diagnosis of
Ibex and Alverno Laboratories sign multi-year, multi-tissue expansion agreement of AI for cancer diagnosis
Alverno Strengthens Its Diagnostics Portfolio and Deploys Ibex’s Suite of AI Solutions, Bringing Improved Cancer Care for Patients Across Its
Ibex scoops second win of the UK Artificial Intelligence Award with leading NHS trusts
NHS Invests £123 million in AI, Accelerating Nationwide Adoption Including Deployment of Ibex Breast Solution Across Five NHS Trusts Tel
Ibex and Medipath sign multi-year, multi-site and multi-tissue expansion of AI for cancer diagnosis across France
Medipath becomes a global AI-powerhouse with the deployment of Ibex solutions across 30 laboratories in France Tel Aviv, Israel, and Frejus,